Total Funding
25
65
Total FundingPrivate Equity raised
Growth Score 25 in past quarter
-5 pts
Heat Score 65 in past quarter
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
81827
Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space.
- Sriram Ramanathan: President & COOPast Role: Nevakar, COO
Navneet Puri: Chairman and CEOPast Role: Pfizer, Vice President - Worldwide R&D, and President - InnoPharma
About the Company
Nevakar is a specialty pharmaceutical company that focuses on the development of innovative products in the injectable and ophthalmic space. Their goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts. Nevakar’s business
model is supported by state-of-the-art R&D infrastructure, located in the NJ Center of Excellence, and a well-experienced management and leadership team.
